Filter Results:
(4,668)
Show Results For
- All HBS Web
(4,668)
- People (16)
- News (1,877)
- Research (2,243)
- Events (2)
- Multimedia (220)
- Faculty Publications (1,828)
Show Results For
- All HBS Web
(4,668)
- People (16)
- News (1,877)
- Research (2,243)
- Events (2)
- Multimedia (220)
- Faculty Publications (1,828)
- Web
MS/MBA Biotechnology: Life Sciences | MBA
and life science community include, the Harvard Business School (HBS) Health Care Initiative (HCI), HBS Blavatnik Fellowship in Life Science Entrepreneurship, the Harvard Biotech Club, the HBS View Details
- December 1998 (Revised September 1999)
- Case
Novartis: Betting on Life Sciences
By: Ray A. Goldberg, Carin-Isabel Knoop and Srinivas Sunder
The merger of Ciba-Geigy and Sandoz produced genomic-based synergies for health care, agribusiness, and nutritional supplements. How to build on the strength of the individual divisions and provide synergies that would continue Novartis' leadership role is the question... View Details
Keywords: Mergers and Acquisitions; Business Divisions; Health Care and Treatment; Leadership; Product Positioning; Science-Based Business; Corporate Strategy; Pharmaceutical Industry
Goldberg, Ray A., Carin-Isabel Knoop, and Srinivas Sunder. "Novartis: Betting on Life Sciences." Harvard Business School Case 599-076, December 1998. (Revised September 1999.)
- January 2011 (Revised January 2012)
- Supplement
The Case of the Unidentified Healthcare Companies2010 (CW)
By: Richard M.J. Bohmer, Ethan S Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected rations for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a... View Details
- 21 Aug 2023
- News
You’re More Than Your Job: 3 Tips for a Healthier Work-Life Balance
- August 17, 2016
- Article
How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures
By: Kevin P. Shah, Tracy E. Spinks and Thomas W. Feeley
In 2014, The University of Texas MD Anderson Cancer Center created a streamlined process for developing measure sets for patient-centered outcomes, including provider-generated and patient-reported outcomes, at an accelerated pace. These comprehensive sets are... View Details
Keywords: Information Technology; Measurement and Metrics; Quality; Service Delivery; Health Care and Treatment; Health Industry; Texas
Shah, Kevin P., Tracy E. Spinks, and Thomas W. Feeley. "How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures." NEJM Catalyst (August 17, 2016).
- September 2014
- Article
Defining the Value of Proton Therapy Using Time-Driven Activity-Based Costing
By: N.G. Thaker, A.B. Guzman, Thomas W. Feeley, T.M. Jones, J.R. Incalcaterra, C. Kolom, S.J. Frank, L.S. Tatum, Ronald S. Walters, Scott B. Cantor, D.I. Rosenthal, A.S. Garden, G.B. Gunn, C.D. Fuller and M.B. Palmer
Technological innovations in radiation therapy (RT) have rapidly improved the quality of care for patients with head and neck cancer. Intensity-modulated proton therapy (MPT) holds promise of further improving outcomes compared with the current photon-based technique... View Details
Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Technological Innovation; Activity Based Costing and Management
Thaker, N.G., A.B. Guzman, Thomas W. Feeley, T.M. Jones, J.R. Incalcaterra, C. Kolom, S.J. Frank, L.S. Tatum, Ronald S. Walters, Scott B. Cantor, D.I. Rosenthal, A.S. Garden, G.B. Gunn, C.D. Fuller, and M.B. Palmer. "Defining the Value of Proton Therapy Using Time-Driven Activity-Based Costing." Oncology Payers, no. 1 (September 2014): 22–28.
- 30 Aug 2011
- First Look
First Look: August 30
customers in the East, emerging markets, and growing interest in health and beauty care among men all over the world. Employing both traditional and innovative marketing techniques, L'Oréal worked to double... View Details
Keywords: Sean Silverthorne
- 22 Aug 2005
- Research & Ideas
Balancing the Future Against Today’s Needs
It is a classic leadership challenge of the early twenty-first century: How do you steer your business and motivate your people to pursue breakthrough growth while giving proper attention to executing the here and now with the utmost care... View Details
Keywords: by Paul Michelman
- 21 Apr 2009
- First Look
First Look: April 21, 2009
distinguishing between direct and complementary spillovers, we examine (1) the extent to which a hospital's specialization in areas related to cardiovascular care directly impacts performance in cardiovascular View Details
Keywords: Martha Lagace
- 02 Sep 2014
- First Look
First Look: September 2
legacy labor and health care costs-is seriously incomplete and that GM's share collapsed for many of the same reasons that many of the other highly successful American firms of the 50s, 60s, and 70s were... View Details
Keywords: Sean Silverthorne
Amy C. Edmondson
Amy C. Edmondson is the Novartis Professor of Leadership and Management at the Harvard Business School, a chair established to support the study of human interactions that lead to the creation of successful enterprises that contribute to the betterment of... View Details
- 05 Sep 2017
- News
Bargaining With Cancer Patients About Treatment
- June 2001 (Revised May 2002)
- Case
Spir-It, Inc. (B): Managing People
When Jack Sindler founded Spir-it, Inc. in 1934, he was the company's sole employee. By 1999, Sindler's firm more than survived its first 55 years. Employment was up to nearly 200, with facilities in two states and work done in three shifts. The product line--which had... View Details
Keywords: Growth Management; Production; Business Growth and Maturation; Interpersonal Communication; Logistics; Human Resources; Diversity Characteristics; Manufacturing Industry
Spear, Steven J. "Spir-It, Inc. (B): Managing People." Harvard Business School Case 601-091, June 2001. (Revised May 2002.)
- 06 Nov 2013
- News
Six Ways to Save Obamacare
- 13 Apr 2017
- News
What Precision Medicine Can Learn from the NFL
- 08 Jun 2020
- News
Tenants and Investors Will Be Looking for Healthy Buildings
- 22 Sep 2016
- News
The Road to Successful Bundled Payment Risk
- 04 Nov 2015
- News
M.B.A.s Get Lessons in Income Inequality
- October 2022
- Case
Afrigen Biologics: Vaccines for the Global South
By: Debora L. Spar and Julia Comeau
The majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO)... View Details
Keywords: Vaccination; Vaccine; mRNA; COVID; COVID-19; Inequity; Hub-and-spoke; Health Care and Treatment; Health Pandemics; Production; Social Issues; Business and Government Relations; South Africa; Africa
Spar, Debora L., and Julia Comeau. "Afrigen Biologics: Vaccines for the Global South." Harvard Business School Case 323-030, October 2022.